Back
Voya Global Equity Dividend and Premium Opportunity Fund Vs. Neurogene Industry Stock Comparison
Sell
45
IGD
Voya Global Equity Dividend and Premium Opportunity Fund
Last Price:
5.51
Seasonality Move:
-0.93%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Sell
45
Voya Global Equity Dividend and Premium Opportunity Fund (IGD)
is a Sell
Is Voya Global Equity Dividend and Premium Opportunity Fund a Buy, Sell or Hold?
- The current Voya Global Equity Dividend and Premium Opportunity Fund [IGD] share price is $5.51. The Score for IGD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- IGD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IGD Stock Price Chart
What is Voya Global Equity Dividend and Premium Opportunity Fund's stock price today?
-
The Voya Global Equity Dividend and Premium Opportunity Fund share price today is $5.51
The current trend is relatively stagnant and IGD is experiencing slight selling pressure.
IGD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 50.21 | Buy |
Chaikin Money Flow: | -39778 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.43 - 5.59) | Sell |
Bollinger Bands (100): | (5.34 - 5.64) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 35.74 | Sell |
Chaikin Money Flow: | -452975 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.4 - 61.5) | Sell |
Bollinger Bands (100): | (34.32 - 50.52) | Sell |
IGD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.51 | Buy |
20-day SMA: | 5.49 | Buy |
50-day SMA: | 5.55 | Sell |
200-day SMA: | 5.31 | Buy |
8-day EMA: | 5.5 | Buy |
20-day EMA: | 5.5 | Buy |
50-day EMA: | 5.51 | Sell |
200-day EMA: | 5.36 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.3 | Sell |
20-day SMA: | 51.47 | Sell |
50-day SMA: | 46.76 | Sell |
200-day SMA: | 38.99 | Sell |
8-day EMA: | 47.13 | Sell |
20-day EMA: | 50.2 | Sell |
50-day EMA: | 47.47 | Sell |
200-day EMA: | 38.44 | Sell |
Voya Global Equity Dividend and Premium Opportunity Fund Earnings Growth & IGD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Voya Global Equity Dividend and Premium Opportunity Fund Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |